ARCHIVES

NCI Advisory Group, Other Cancer Meeting

This article is from The Cancer Letter archive.

Vol. 04 No. 21 | May 26, 1978

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

It’s “High Noon” For Cancer, Vice President Says

October 2, 1998

FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots

October 14, 1988

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982

Herceptin Lowers Recurrence In Early Breast Cancer

November 25, 2005

Congress Deluged With Protests From Biomedical Researchers Over Grants Reduction, Budget Cuts

February 15, 1985